Search PubMed⌕ Search

Biomedical subjects

F Sicuteri

Publications and source records attributed to F Sicuteri.

At least 127 records · Page 7Linked to original sources

Urinary excretion of kallikrein following myocardial infarction.

Kinin has been hypothesized to be involved in the mechanism of the procordialgia, collapse, and shock in myocardial infarction. In spontaneous and experimental animal infarction, the long-lasting lowering of plasma kininogen is perhaps the expression of kinin release from the plasma precursor. More recently, a durable reduction of plasma prekallikrein and of the plasma inhibitor of kallikrein, both evaluated with the kaolin contact method, has been demonstrated to support the implication of the kinin system in the course of myocardial infarction. In the present study, the dialy urinary excretion of kallikrein, according to the Porcelli and Croxatto method, has been studied in a group of patients with acute myocardial infarction and in a group of control patients, Differences between the two groups have been observed. They consist mainly in strong daily oscillations in the amount of urinary kallikrein excretion during the 24 hour period in the group of patients with myocardial infaction. At this moment, however, it is not possible to give a definite interpretation of these results.

Humans↗

Clinical and animal pharmacology of migraine: new perspectives.

Animal and clinical pharmacological studies show in certain vascular beds a biphasic action [potentiation and inhibition of serotonin (5-HT) responses] of some anti-migraine drugs, such as ergotamine, methysergide and more recently Org GC 94. Potentiation occurs at therapeutic drug concentrations. The present investigations seem to support the 5-HT theory of migraine and other essential headaches. In this theory, anti-migraine drugs, such as ergotamine, methysergide, pizotifen, and Org GC 94 could reduce the occurrence of pain in migraine and other esscutial headaches by acting as partial agonists tending to correct a deficiency of central 5-HT concentrations or turnover.

Animals↗

Serotonin vascular reactivity and other clinical pharmacological investigations in two intestinal carcinoid patients.

In two patients with carcinoid syndrome, a reduced venoreactivity to serotonin (5-HT) was found by means of the venoconstriction test. Parachlorophenylalanine (PCPA) treatment increased 5-HT venoreactivity. A normal noradrenaline venoreactivity was detected before and during PCPA administration. The altered platelet monoamine oxidase (MAO) activity corrected by PCPA treatment. The abnormal 5-HT turnover may alter the synthesis of MAO and provoke the production of isoenzymes. Low plasma amine oxidase and high plasma histaminase activity were found in 1 of these 2 patients. A low level of plasma prekallikrein in the two patients remained unchanged during PCPA administration.

Amine Oxidase (Copper-Containing)↗

Sex, migraine and serotonin interrelationships.

Sexual deficiency or frank impotence in man could be due to an imbalance of monoamines, particularly 5-HT, at the mating center level. An absolute or relative excess of 5-HT seems to antagonize testosterone at the level of the mating center receptors in the brain. Plasma testosterone levels in so-called psychological impotence are normal. When the 5-HT concentration in sexually deficient men is sufficiently decreased with parachlorophenylalanine (PCPA) treatment and testosterone levels increased following its administration, a vivid sexual stimulation appears in about half of the untractable cases. Similar results are observed by substituting testosterone with monoamine oxydase inhibitor (MAOI) in PCPA-treated volunteers. Furthermore, MAOI-PCPA are administered to emphasize the brain shift between serotonin and catecholamines. Yet the PCPA-MAOI treatment avoids the prostate carcinogenic risk of testosterone administration in aging males, and seems to have euphorizing effects stronger than those expected only from MAOI therapy. Because of the several side effects of PCPA-MAOI testosterone, the present experiments should be interpreted very cautiously.

5-Hydroxytryptophan↗

Monoamine oxidase defect in essential arterial hypertension. A single dose pargyline test.

A defect in the level of monoamine oxidase activity of platelets was observed in essential arterial hypertension. This defect seems dependent upon a lower rate of synthesis of the enzyme and not to the presence of an isoenzyme, as the net rate of return of the enzymatic activity after pargyline inhibition does not significantly differ between hypertensive and normotensive subjects.

Adult↗

[Aphrodisiac action of MAO inhibitors and of parachlorophenylalanine (PCPA) in sexual asthenias].

The sexual function in man can be modified decreasing brain serotonin by PCPA and increasing brain cathecolamines by monoamineoxidase inhibitors. In 5 volunteers, sexual deficient men, the combination of PCPA with phenelzine (IMAO) stressed an increase in sexual stimulation, measured by number of erections. In two subjects this effect lasted for 2 months. A clear improvement in mood has also been shown. This pharmacological combination opens new and interesting possibilities in sexual deficiency treatment.

Adult↗

The influence of tryptophan and parachlorophenylalanine on the sexual activity in man.

The effects on the sexual tone of parachlorophenylalanine, a selective inhibtor of 5-hydroxytryptamine synthesis, testosterone and placebo were evaluated in patients complaining of migraine-headache and sexual deficiency. The combined treatment with parachlorophenylalanine and testosterone significantly increases the sexual stimulus more than parachlorophenylalanine, testosterone and placebo, when given on their own. Conversely subjects with normal or excessive sexual activity, reported a decrease of sexual tone, during chronic treatment with tryptophan. The hypothesis of an implication of brain 5-HT in the mechanism of psychogenic sexual deficiency and the possibility of a therapeutic approach with drugs able to interfere with 5-HT turnover are discussed.

Adolescent↗